Green Leaf Lab has announced the availability of in-house testing for Hop Latent Viroid (HpLVd) in Oregon. This development marks a significant step in ensuring the health and potency of cannabis and hemp plants, addressing a critical issue facing the industry.
HpLVd, a single-stranded, circular infectious RNA, is a persistent challenge in the hemp and cannabis industry. While it does not kill the plant, HpLVd can drastically reduce the plant's efficacy at harvest and negatively impact flower and cannabinoid growth. Similar to viruses in humans and animals, HpLVd is often asymptomatic in Cannabis sativa, making it difficult to detect without proper testing. Despite the lack of visible symptoms, the impact on plant potency and flower growth is severe. Infected plants may produce only half the cannabinoid content compared to healthy ones and reduce flower growth overall.
"At Green Leaf Lab, we are committed to providing the highest quality testing services to support the cannabis and hemp industries," said Rowshan Reordan, CEO of Green Leaf Lab. "The introduction of in-house HpLVd testing is part of our ongoing effort to ensure that our clients can maintain the integrity and potency of their products. Early detection of HpLVd is crucial, and our advanced testing capabilities will help growers manage and mitigate the impact of this viroid."
Green Leaf Lab's in-house testing for HpLVd is designed to provide accurate, reliable, and timely results. This service will enable cultivators to take proactive measures in managing plant health, ensuring higher yields and maintaining the desired cannabinoid profiles in their crops.
For more information:
Green Leaf Lab
www.greenleaflab.org